Add Company
Join Now

Oblique Therapeutics Revenue and Competitors

License our Company Data API

Göteborg, SWE

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Oblique Therapeutics's estimated annual revenue is currently $4.4M per year.(i)
  • Oblique Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Oblique Therapeutics has 22 Employees.(i)
  • Oblique Therapeutics grew their employee count by 0% last year.

Oblique Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.3M10625%N/AN/A
#2
$61.7M3075%N/AN/A
#3
$15.1M75-12%N/AN/A
#4
$120.6M60022%N/AN/A
#5
$29.7M14821%N/AN/A
#6
$27.7M138-67%N/AN/A
#7
$31.2M15514%N/AN/A
#8
$25.3M12629%N/AN/A
#9
$108.7M54126%N/AN/A
#10
$1200M1397-6%$2.4BN/A
Add Company

What Is Oblique Therapeutics?

Oblique Therapeutics is a privately held Swedish biotech, developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and aggressive metastatic cancer. The company uses Abiprot an in house- invented next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.. We make medicines that matter to patients.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$4.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oblique Therapeutics News

2022-03-30 - Lumakras Drug Market Share Analysis 2022 Growth, Size Estimates, Global Revenues, Industry Trends & Upcoming

... Mirati Therapeutics Inc., Moderna Inc., Oblique Therapeutics AB, ... popularity of advanced therapies, are fuelling the market growth.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.9M22N/AN/A
#2
$4M23-12%N/A
#3
$2.5M2644%N/A
#4
$6.2M274%N/A
#5
$1.7M28-15%N/A